Insider · CIK 0001975257
Yan Zhang
Files at EVFM (Evofem Biosciences, Inc.). First filing Jan 12, 2024, latest Jan 12, 2024.
In brief
Yan Zhang files SEC Form 4 as CFO at EVFM (Evofem Biosciences, Inc.). Since Jan 12, 2024, Yan Zhang has reported 0 open-market buys worth $0 and 1 open-market sell worth $4, the latest filed on Jan 12, 2024.
A track record needs three past buys with six months of prices behind them; Yan Zhang has 0, so none is measured yet.
The newest scored trade: sold $4 of EVFM on Jan 12, 2024, filed Jan 12, 2024, scored 42 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVFM: Evofem Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | EVFMsell Evofem Biosciences, Inc. | $4 104 shares | -100% | +3% from low-100% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | EVFM Evofem Biosciences, Inc. | SOpen-market sale Common Stock | -104 | $0.04 | $4 | 0 | Jan 12, 2024 |
Questions about Yan Zhang
Answered from the filings on this page, as of the latest one.
Is Yan Zhang buying or selling?
Not in the last 12 months. Yan Zhang's latest open-market trade on SEC Form 4 was sold $4 of EVFM on Jan 12, 2024.
How did Yan Zhang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yan Zhang has 0.
Where does Yan Zhang file Form 4?
Yan Zhang has filed Form 4 at EVFM (Evofem Biosciences, Inc.) as CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.